Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Mei-Mei LiYun-Qiang TangYuan-Feng GongWei ChengHao-Long LiFan-En KongWen-Jie ZhuShan-Shan LiuLi HuangXin-Yuan GuanNing-Fang MaMing LiuPublished in: BMC cancer (2019)
An oncogenic dedifferentiation SOX signature presents a great potential in predicting prognostic significance in HCC, and might provide novel biomarkers for precision oncology further in the clinic.